Dr. Shlomo Pascal, MD

Dr. Pascal practices at Fort Lauderdale Behavioral Health Center in Oakland Park, Florida, part of Universal Health Services.

Dr. Pascal's NPI, 1124171616, was assigned on January 19, 2007. Dr. Pascal graduated from Carol Davila University of Medicine and Pharmacy in 1983. Dr. Pascal holds Florida license 76692.

Dr. Pascal's primary practice is Fort Lauderdale Behavioral Health Center, at 5757 N Dixie Hwy, Oakland Park, FL 33334 in Broward County. The practice phone is (954) 734-2000.

Dr. Pascal's primary practice is Fort Lauderdale Behavioral Health Center in Oakland Park, Florida, part of Universal Health Services. The medical group on file is Fort Lauderdale Behavioral Health Center. Dmand AI also links Dr. Pascal to 2 more medical groups and 1 group practice or clinic, each named with a free account. Dr. Pascal's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Pascal practices, 2 sites in all. Vendor and product names are available with a free account.

Psychiatry is Dr. Pascal's primary specialty in the NPI Registry, under taxonomy code 2084P0800X. Dr. Pascal is licensed in Florida.

Dmand AI lists ADHD, anxiety, bipolar disorder, depression, psychoses and substance abuse among the conditions Dr. Pascal treats.

CMS data shows 1,233 Medicare services from Dr. Pascal across 7 procedure codes in 2024, for 318 Medicare patients. Medicare paid $91,381 for them.

CMS counts 318 Medicare patients who saw Dr. Pascal in 2024. The largest group is under 65, with 179 patients. 75% of them have anxiety, and 75% have depression. 73% are also on Medicaid. Their average risk score is 1.56, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Pascal's median patient age at 16, with 61% women.

In 2024, Dr. Pascal wrote 2,539 Medicare Part D claims for 255 patients. 94% of them were for generic drugs. CMS names the drug for 2,231 of them, across 59 drugs with 11 or more claims each, at $221,901 in total drug cost. In 2023, CMS named 4,054 claims across 73 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 96 out of 100 for Dr. Pascal for performance year 2024, reported as part of a group. Dr. Pascal accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Pascal as offering telehealth.

Dmand AI links 4 papers to Dr. Pascal. The most frequent topics are Brain and Glucose. Dr. Pascal has published most often in J Cereb Blood Flow Metab. Dr. Pascal's most frequent co-authors are Ranjan Duara, MD, Rakesh K. Sharma, MD and Jon A. Shaw, MD.

CMS Open Payments shows 328 general payments to Dr. Pascal from 25 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 95% of the total. Janssen Pharmaceuticals, Inc paid the most, $1,952.

Dr. Pascal graduated from Carol Davila University of Medicine and Pharmacy in 1983.

Dr. Pascal is in network with 7 carriers, including Aetna, United Healthcare and Alliant Health Plans. PPO plans come from the most carriers, 4. Check the plan with the practice before a visit.